K. Coeleveld

488 total citations
30 papers, 374 citations indexed

About

K. Coeleveld is a scholar working on Rheumatology, Hematology and Pharmacology. According to data from OpenAlex, K. Coeleveld has authored 30 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 11 papers in Hematology and 9 papers in Pharmacology. Recurrent topics in K. Coeleveld's work include Osteoarthritis Treatment and Mechanisms (18 papers), Hemophilia Treatment and Research (11 papers) and Inflammatory mediators and NSAID effects (9 papers). K. Coeleveld is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (18 papers), Hemophilia Treatment and Research (11 papers) and Inflammatory mediators and NSAID effects (9 papers). K. Coeleveld collaborates with scholars based in Netherlands, Germany and Denmark. K. Coeleveld's co-authors include S.C. Mastbergen, Floris P. J. G. Lafeber, G. Roosendaal, Roger E. G. Schutgens, Laurens Nieuwenhuizen, Douwe H. Biesma, Lize F. D. van Vulpen, Harrie Weinans, F.P.J.G. Lafeber and M. E. R. van Meegeren and has published in prestigious journals such as Blood, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

K. Coeleveld

30 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Coeleveld Netherlands 12 176 142 84 70 63 30 374
Antonietta Fazio Italy 10 141 0.8× 36 0.3× 139 1.7× 216 3.1× 56 0.9× 23 458
Shanxing Zhang China 12 181 1.0× 40 0.3× 64 0.8× 174 2.5× 119 1.9× 22 465
Wanming Zhao United States 8 71 0.4× 118 0.8× 198 2.4× 210 3.0× 32 0.5× 9 384
Menglei Xu China 10 90 0.5× 29 0.2× 29 0.3× 193 2.8× 69 1.1× 34 365
Koichiro Komiya Japan 6 232 1.3× 20 0.1× 18 0.2× 146 2.1× 78 1.2× 10 394
Xu Cao China 12 132 0.8× 11 0.1× 32 0.4× 123 1.8× 38 0.6× 19 293
Karolina Kania United Kingdom 6 209 1.2× 9 0.1× 109 1.3× 163 2.3× 94 1.5× 8 412
Bunichiro Izumi Japan 12 61 0.3× 27 0.2× 33 0.4× 231 3.3× 171 2.7× 21 577
Yoshinari Fujita Japan 7 132 0.8× 22 0.2× 11 0.1× 91 1.3× 50 0.8× 10 292
Naimisha Beeravolu United States 7 21 0.1× 23 0.2× 162 1.9× 115 1.6× 107 1.7× 10 322

Countries citing papers authored by K. Coeleveld

Since Specialization
Citations

This map shows the geographic impact of K. Coeleveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Coeleveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Coeleveld more than expected).

Fields of papers citing papers by K. Coeleveld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Coeleveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Coeleveld. The network helps show where K. Coeleveld may publish in the future.

Co-authorship network of co-authors of K. Coeleveld

This figure shows the co-authorship network connecting the top 25 collaborators of K. Coeleveld. A scholar is included among the top collaborators of K. Coeleveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Coeleveld. K. Coeleveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korthagen, N.M., K. Coeleveld, Malin Becker, et al.. (2023). Microencapsulated stem cells reduce cartilage damage in a material dependent manner following minimally invasive intra-articular injection in an OA rat model. Materials Today Bio. 22. 100791–100791. 8 indexed citations
2.
Meij, Björn P., K. Coeleveld, Irene S. Ludwig, et al.. (2022). The catabolic-to-anabolic shift seen in the canine osteoarthritic cartilage treated with knee joint distraction occurs after the distraction period. Journal of Orthopaedic Translation. 38. 44–55. 5 indexed citations
3.
Visser, Harry, F.P.J.G. Lafeber, K. Coeleveld, et al.. (2021). IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model. Cartilage. 13(2_suppl). 1155S–1164S. 5 indexed citations
4.
Coeleveld, K., et al.. (2020). Knee joint distraction-induced shift from catabolic to anabolic state occurs after the distraction period. Osteoarthritis and Cartilage. 28. S76–S77. 2 indexed citations
5.
Eijkelkamp, Niels, K. Coeleveld, Marianna A. Tryfonidou, et al.. (2019). Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study. PLoS ONE. 14(7). e0219587–e0219587. 14 indexed citations
6.
Mastbergen, S.C., K. Coeleveld, C. Erik Hack, et al.. (2018). IL4-10 fusion protein has chondroprotective, anti-inflammatory and potentially analgesic effects in the treatment of osteoarthritis. Osteoarthritis and Cartilage. 26(8). 1127–1135. 27 indexed citations
7.
Visser, Harry, et al.. (2018). IL4-10 fusion protein as a disease modifying therapy for osteoarthritis evaluated in a rat groove model in vivo. Osteoarthritis and Cartilage. 26. S292–S292. 1 indexed citations
8.
9.
Mastbergen, S.C., A.E. Kozijn, K. Coeleveld, et al.. (2017). Metabolic dysregulation accelerates injury‐induced joint degeneration, driven by local inflammation; an in vivo rat study. Journal of Orthopaedic Research®. 36(3). 881–890. 29 indexed citations
10.
Coeleveld, K., et al.. (2017). Effects of the human IL4-10 fusion protein in the canine groove model of osteoarthritis. Osteoarthritis and Cartilage. 25. S434–S434. 1 indexed citations
11.
Coeleveld, K., A.M. Huisman, J. W. J. Bijlsma, et al.. (2017). Lack of a clear disease modifying activity of celecoxib in treatment of end-stage knee osteoarthritis: a rondomized observer blinded clinical trial. Osteoarthritis and Cartilage. 25. S420–S421. 3 indexed citations
12.
Vulpen, Lize F. D. van, M. E. R. van Meegeren, K. Coeleveld, et al.. (2017). A fusion protein of interleukin‐4 and interleukin‐10 protects against blood‐induced cartilage damage in vitro and in vivo. Journal of Thrombosis and Haemostasis. 15(9). 1788–1798. 19 indexed citations
13.
Weinans, Harrie, et al.. (2016). Groove model of tibia‐femoral osteoarthritis in the rat. Journal of Orthopaedic Research®. 35(3). 496–505. 21 indexed citations
14.
Schutgens, Roger E. G., et al.. (2016). A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo. Osteoarthritis and Cartilage. 24. S505–S505. 9 indexed citations
15.
Visser, Harry, et al.. (2016). The groove model of tibia-femoral osteoarthritis in the rat. Osteoarthritis and Cartilage. 24. S400–S401. 1 indexed citations
16.
Miranda‐Duarte, Antonio, et al.. (2015). Intrinsic cartilage repair by joint distraction is triggered by a regenerative transcriptional response. Osteoarthritis and Cartilage. 23. A269–A269. 1 indexed citations
17.
Roosendaal, G., S.C. Mastbergen, K. Coeleveld, et al.. (2014). Deferasirox limits cartilage damage following haemarthrosis in haemophilic mice. Thrombosis and Haemostasis. 112(11). 1044–1050. 15 indexed citations
18.
Nieuwenhuizen, Laurens, G. Roosendaal, S.C. Mastbergen, et al.. (2013). Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice. Journal of Thrombosis and Haemostasis. 12(2). 237–245. 14 indexed citations
19.
Roosendaal, G., et al.. (2013). A single intra-articular injection with IL-4 plus IL-10 ameliorates blood-induced cartilage degeneration in haemophilic mice. Osteoarthritis and Cartilage. 21. S291–S292. 3 indexed citations
20.
Roosendaal, G., K. Coeleveld, Erik Lubberts, et al.. (2013). Haemarthrosis stimulates the synovial fibrinolytic system in haemophilic mice. Thrombosis and Haemostasis. 110(7). 173–183. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026